ES
Eisai Co., Ltd.
ESAIY · OTC
$8.00 -0.62% (-$0.05)
1M +5.54%
Market Cap ¥1.42T
P/E Ratio 33.08x
Div. Yield 2.85%
ROE 4.83%
Bulios Fair Price
$6.6
17.5% downside
Current Price
$8
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ESAIY is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
51 /100
Fair EV/EBITDA 14.58x
P/S 1.63x
P/B 1.58x
Growth
29 /100
Declining Rev. growth 5.54%
Book val. growth 4.12%
EPS growth 8.73%
Profitability
46 /100
Moderate Net margin 4.93%
Op. margin 5.10%
FCF margin 5.54%
Quality
22 /100
Poor ROE 4.83%
ROA 2.78%
Asset turnover 0.56x
Debt
96 /100
Low Current ratio 2.24x
Int. coverage 8.47x
Net debt/EBITDA -0.42x
Stability
86 /100
Stable Rev. volatility 5.65%
EPS volatility 17.27%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ESAIY
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Haruo Naito
Employees
10,543
Headquarters
Tokyo